Q1 2024 Alembic Pharmaceuticals Ltd Earnings Call Transcript

Aug 04, 2023 / 11:30AM GMT
Operator

Ladies and gentlemen, good day, and welcome to Alembic Pharmaceuticals Limited Discussion on company's Q1 Unaudited Financial Results Conference Call. We have with us today, Mr. Pranav Amin, Managing Director; Mr. Shaunak Amin, Managing Director; Mr. R.K. Baheti, Director, Finance and CFO; Mr. Mitanshu Shah, Head Finance; Mr. Jesal Shah, Head Strategy; and Mr. Ajay Kumar Desai, Senior VP Finance.

(Operator Instructions). Please note that this conference is being recorded. I would now like to hand the conference over to Mr. R.K. Baheti. Thank you, and over to you, sir.

Raj Kumar Shreeram Baheti - Alembic Pharmaceuticals Limited - Director of Finance, CFO & Executive Director

Thank you. Good evening, everyone. Thank you all for joining the first quarter results conference call. I'm sure you have got to their views by now. Let me briefly take you through the financial numbers.

During the quarter, our total revenue grew 18% to INR 1,486 crores, EBITDA is INR 210 crores, which is 14.1% of sales and grew by 67% before considering nonleaking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot